Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

bacterial meningitis - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

bacterial meningitis

MONDO:0006670

Also known as:Bacteria caused infectious meningitisBacteria infectious meningitismeningitis, bacterial

Find Clinical TrialsTrials

Overview

Inflammation of the membranes surrounding the brain and spinal cord due to a bacterial infection.

Treatments2 FDA approved

Clinical Trials12 registered · 8 recruiting

Diagnosis

Biomarker and diagnostic research for bacterial meningitis has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

2 FDA-approved treatments are available for bacterial meningitis, including MEROPENEM (MEROPENEM, approved 2023) and MEROPENEM AND SODIUM CHLORIDE (MEROPENEM AND SODIUM CHLORIDE, approved 2015).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

12 clinical trials registered, 8 recruiting. Interventions under study include other interventions, drug therapy, and procedural interventions. Pipeline includes 2 PHASE2, 1 PHASE1, 2 NA. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT02979951](https://clinicaltrials.gov/study/NCT02979951)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 7:47 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

GARD

Genetic and Rare Diseases Info Center

GARD:5881

Questions for Your Care Team

→What are the benefits and potential side effects of MEROPENEM for managing bacterial meningitis?
→Are any of the 12 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	75	30%
Research summaries	49	20%
Patient case studies	35	14%
Laboratory research	31	13%
Testing and diagnosis research	28	11%
Clinical study results	24	10%
New treatment approaches	4	2%
Other research	1	0%

Kisho

bacterial meningitis

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

External Resources

GARD

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

CDC Telebriefing: Status of Serogroup B Meningitis Cases in the United States - Transcript

CDC Telebriefing: Status of Serogroup B Meningitis Cases in the United States - Media Advisory

bacterial meningitis

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

CDC Telebriefing: Status of Serogroup B Meningitis Cases in the United States - Transcript

CDC Telebriefing: Status of Serogroup B Meningitis Cases in the United States - Media Advisory